Influence of oral lactoferrin on Mycobacterium tuberculosis induced immunopathology

Tuberculosis

Volumn 91, Issue SUPPL. 1, 2011, Pages

  Welsh, Kerry J ^a   Hwang, Shen An ^a   Boyd, Sydney ^a   Kruzel, Marian L ^a   Hunter, Robert L ^a   Actor, Jeffrey K ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

IL 17; Immunopathology; Lactoferrin; Tuberculosis

Indexed keywords

INTERLEUKIN 17; LACTOFERRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL LOAD; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HISTOPATHOLOGIC SKIN REACTION; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; TH1 CELL; TISSUE INJURY; TUBERCULOSIS;

ADMINISTRATION, ORAL; ANIMALS; ANTITUBERCULAR AGENTS; CELLS, CULTURED; COLONY COUNT, MICROBIAL; CYTOKINES; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; FEMALE; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; INTERLEUKIN-17; LACTOFERRIN; LUNG; MACROPHAGES; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; SPLEEN; TH1 CELLS; TUBERCULOSIS, PULMONARY;

EID: 84655164969     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2011.10.019     Document Type: Article

References (57)

1. WHO. WHO report 2009 Global tuberculosis control. Epidemiology, strategy, financing 2009 World Health Organization Geneva
2. CDC Treatment of tuberculosis MMWR 52 2003 1 77
3. M.H. Cynamon Chemotherapeutic agents for mycobacterial infections L.N. Friedman, Tuberculosis: current concepts and treatment 2001 CRC Press New York 301 330
4. D.O. Co, L.H. Hogan, S.I. Kim, and M. Sandor Mycobacterial granulomas: keys to a long-lasting host-pathogen relationship Clin Immunol 113 2004 130 136 (Pubitemid 39296843)
5. A. Rao, and O. Avni Molecular aspects of T-cell differentiation Br Med Bull 56 2000 969 984 (Pubitemid 32417163)
6. S.A. Khader, G.K. Bell, J.E. Pearl, J.J. Fountain, J. Rangel-Moreno, G.E. Cilley, F. Shen, S.M. Eaton, S.L. Gaffen, S.L. Swain, R.M. Locksley, L. Haynes, T.D. Randall, and A.M. Cooper IL-23 and IL-17 in the establishment of protective pulmonary CD4 + T cell responses after vaccination and during Mycobacterium tuberculosis challenge Nat Immunol 8 2007 369 377 (Pubitemid 46745412)
7. Y. Okamoto Yoshida, M. Umemura, A. Yahagi, R.L. O'Brien, K. Ikuta, K. Kishihara, H. Hara, S. Nakae, Y. Iwakura, and G. Matsuzaki Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung J Immunol 184 2010 4414 4422
8. T.M. Wozniak, A.A. Ryan, and W.J. Britton Interleukin-23 restores immunity to Mycobacterium tuberculosis infection in IL-12p40-deficient mice and is not required for the development of IL-17-secreting T cell responses J Immunol 177 2006 8684 8692 (Pubitemid 44893833)
9. K.I. Happel, E.A. Lockhart, C.M. Mason, E. Porretta, E. Keoshkerian, A.R. Odden, S. Nelson, and A.J. Ramsay Pulmonary interleukin-23 gene delivery increases local T-cell immunity and controls growth of Mycobacterium tuberculosis in the lungs Infect Immun 73 2005 5782 5788 (Pubitemid 41193014)
10. A.M. Cooper, K.D. Mayer-Barber, and A. Sher Role of innate cytokines in mycobacterial infection Mucosal Immunol 4 2011 252 260
11. D.G. Russell, P.J. Cardona, M.J. Kim, S. Allain, and F. Altare Foamy macrophages and the progression of the human tuberculosis granuloma Nat Immunol 10 2009 943 948
12. C. Paige, and W.R. Bishai Penitentiary or penthouse condo: the tuberculous granuloma from the microbe's point of view Cell Microbiol 12 2010 301 309
13. G.J. Churchyard, G. Kaplan, D. Fallows, R.S. Wallis, P. Onyebujoh, and G.A. Rook Advances in immunotherapy for tuberculosis treatment Clin Chest Med 30 2009 769 782 [ix]
14. L.G. Wayne, and C.D. Sohaskey Nonreplicating persistence of Mycobacterium tuberculosis Annu Rev Microbiol 55 2001 139 163 (Pubitemid 32978103)
15. E. Roy, D.B. Lowrie, and S.R. Jolles Current strategies in TB immunotherapy Curr Mol Med 7 2007 373 386 (Pubitemid 46979701)
16. J.K. Actor, S.A. Hwang, and M.L. Kruzel Lactoferrin as a natural immune modulator Curr Pharm Des 15 2009 1956 1973
17. S.A. Hwang, and J.K. Actor Lactoferrin modulation of BCG-infected dendritic cell functions Int Immunol 21 2009 1185 1197
18. S.A. Hwang, R. Arora, M.L. Kruzel, and J.K. Actor Lactoferrin enhances efficacy of the BCG vaccine: comparison between two inbred mice strains (C57BL/6 and BALB/c) Tuberculosis (Edinb) 89 Suppl. 1 2009 S49 S54
19. S.A. Hwang, M.L. Kruzel, and J.K. Actor Lactoferrin augments BCG vaccine efficacy to generate T helper response and subsequent protection against challenge with virulent Mycobacterium tuberculosis Int Immunopharmacol 5 2005 591 599 (Pubitemid 40430765)
20. S.A. Hwang, M.L. Kruzel, and J.K. Actor Influence of bovine lactoferrin on expression of presentation molecules on BCG-infected bone marrow derived macrophages Biochimie 91 2009 76 85
21. S.A. Hwang, K.M. Wilk, M. Budnicka, M. Olsen, Y.A. Bangale, R.L. Hunter, M.L. Kruzel, and J.K. Actor Lactoferrin enhanced efficacy of the BCG vaccine to generate host protective responses against challenge with virulent Mycobacterium tuberculosis Vaccine 25 2007 6730 6743 (Pubitemid 47332728)
22. M.L. Kruzel, Y. Harari, C.Y. Chen, and G.A. Castro Lactoferrin protects gut mucosal integrity during endotoxemia induced by lipopolysaccharide in mice Inflammation 24 2000 33 44 (Pubitemid 30105938)
23. K.J. Welsh, S.A. Hwang, R.L. Hunter, M.L. Kruzel, and J.K. Actor Lactoferrin modulation of mycobacterial cord factor trehalose 6-6'-dimycolate induced granulomatous response Transl Res 156 2010 207 215
24. S.A. Hwang, K. Wilk, M.L. Kruzel, and J.K. Actor A novel recombinant human lactoferrin augments the BCG vaccine and protects alveolar integrity upon infection with Mycobacterium tuberculosis in mice Vaccine 27 2009 3026 3034
25. S. Yang, and M.C. Healey The immunosuppressive effects of dexamethazone adminstered in drinking water to C57BL/6 mice infected with Cryptosporidium parvum J Parasitol 79 1993 626 630 (Pubitemid 23249757)
26. J. Artym, M. Zimecki, and M.L. Kruzel Reconstitution of the cellular immune response by lactoferrin in cyclophosphamide-treated mice is correlated with renewal of T cell compartment Immunobiology 207 2003 197 205 (Pubitemid 36626302)
27. J. Artym, M. Zimecki, and M.L. Kruzel Effect of lactoferrin on the methotrexate-induced suppression of the cellular and humoral immune response in mice Anticancer Res 24 2004 3831 3836 (Pubitemid 40468672)
28. A.N. Abbott, T.V. Guidry, K.J. Welsh, A.M. Thomas, M.A. Kling, R.L. Hunter, and J.K. Actor 11beta-hydroxysteroid dehydrogenases are regulated during the pulmonary granulomatous response to the mycobacterial glycolipid trehalose-6,6'-dimycolate Neuroimmunomodulation 16 2009 147 154
29. T.V. Guidry, R.L. Hunter Jr., and J.K. Actor Mycobacterial glycolipid trehalose 6,6'-dimycolate-induced hypersensitive granulomas: contribution of CD4+ lymphocytes Microbiology 153 2007 3360 3369 (Pubitemid 47629541)
30. T.A. Wynn, I. Eltoum, A.W. Cheever, F.A. Lewis, W.C. Gause, and A. Sher Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni J Immunol 151 1993 1430 1440 (Pubitemid 23219280)
31. K.J. Welsh, A.N. Abbott, S.A. Hwang, J. Indrigo, L.Y. Armitige, M.R. Blackburn, R.L. Hunter Jr., and J.K. Actor A role for tumour necrosis factor-alpha, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous response Microbiology 154 2008 1813 1824
32. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25 2001 402 408 (Pubitemid 34164012)
33. C. Carranza, E. Juarez, M. Torres, J.J. Ellner, E. Sada, and S.K. Schwander Mycobacterium tuberculosis growth control by lung macrophages and CD8 cells from patient contacts Am J Respir Crit Care Med 173 2006 238 245 (Pubitemid 43187898)
34. M.K. Gately, L.M. Renzetti, J. Magram, A.S. Stern, L. Adorini, U. Gubler, and D.H. Presky The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses Annu Rev Immunol 16 1998 495 521 (Pubitemid 28183374)
35. E.E. Murphy, G. Terres, S.E. Macatonia, C.S. Hsieh, J. Mattson, L. Lanier, M. Wysocka, G. Trinchieri, K. Murphy, and A. O'Garra B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation J Exp Med 180 1994 223 231 (Pubitemid 24181071)
36. S.M. Wahl Transforming growth factor-beta: innately bipolar Curr Opin Immunol 19 2007 55 62 (Pubitemid 46073697)
37. E. Ishikawa, T. Ishikawa, Y.S. Morita, K. Toyonaga, H. Yamada, O. Takeuchi, T. Kinoshita, S. Akira, Y. Yoshikai, and S. Yamasaki Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle J Exp Med 206 2009 2879 2888
38. I. Matsunaga, and D.B. Moody Mincle is a long sought receptor for mycobacterial cord factor J Exp Med 206 2009 2865 2868
39. A.G. Bean, D.R. Roach, H. Briscoe, M.P. France, H. Korner, J.D. Sedgwick, and W.J. Britton Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin J Immunol 162 1999 3504 3511 (Pubitemid 29313602)
40. D.R. Roach, A.G. Bean, C. Demangel, M.P. France, H. Briscoe, and W.J. Britton TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection J Immunol 168 2002 4620 4627 (Pubitemid 34441368)
41. M.L. Kruzel, J.K. Actor, I. Boldogh, and M. Zimecki Lactoferrin in health and disease Postepy Hig Med Dosw (Online) 61 2007 261 267
42. J.K. Actor, S.A. Hwang, M. Olsen, M. Zimecki, R.L. Hunter Jr., and M.L. Kruzel Lactoferrin immunomodulation of DTH response in mice Int Immunopharmacol 2 2002 475 486 (Pubitemid 34169743)
43. K. Yamauchi, H. Wakabayashi, K. Shin, and M. Takase Bovine lactoferrin: benefits and mechanism of action against infections Biochem Cell Biol 84 2006 291 296 (Pubitemid 44341303)
44. K.M. Wilk, S.A. Hwang, and J.K. Actor Lactoferrin modulation of antigen-presenting-cell response to BCG infection Postepy Hig Med Dosw (Online) 61 2007 277 282
45. N. Takakura, H. Wakabayashi, K. Yamauchi, and M. Takase Influences of orally administered lactoferrin on IFN-gamma and IL-10 production by intestinal intraepithelial lymphocytes and mesenteric lymph-node cells Biochem Cell Biol 84 2006 363 368 (Pubitemid 44341312)
46. H. Wakabayashi, N. Takakura, K. Yamauchi, and Y. Tamura Modulation of immunity-related gene expression in small intestines of mice by oral administration of lactoferrin Clin Vaccine Immunol 13 2006 239 245 (Pubitemid 43383793)
47. U.E. Schaible, H.L. Collins, F. Priem, and S.H. Kaufmann Correction of the iron overload defect in beta-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis J Exp Med 196 2002 1507 1513 (Pubitemid 35424944)
48. K. Sorimachi, K. Akimoto, Y. Hattori, T. Ieiri, and A. Niwa Activation of macrophages by lactoferrin: secretion of TNF-alpha, IL-8 and NO Biochem Mol Biol Int 43 1997 79 87 (Pubitemid 28297194)
49. J. Chan, K. Tanaka, D. Carroll, J. Flynn, and B.R. Bloom Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis Infect Immun 63 1995 736 740
50. S.J. Aujla, Y.R. Chan, M. Zheng, M. Fei, D.J. Askew, D.A. Pociask, T.A. Reinhart, F. McAllister, J. Edeal, K. Gaus, S. Husain, J.L. Kreindler, P.J. Dubin, J.M. Pilewski, M.M. Myerburg, C.A. Mason, Y. Iwakura, and J.K. Kolls IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia Nat Med 14 2008 275 281 (Pubitemid 351347908)
51. L. Tsenova, K. Sokol, V.H. Freedman, and G. Kaplan A combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis-associated death J Infect Dis 177 1998 1563 1572 (Pubitemid 28243580)
52. R.S. Wallis, P. Kyambadde, J.L. Johnson, L. Horter, R. Kittle, M. Pohle, C. Ducar, M. Millard, H. Mayanja-Kizza, C. Whalen, and A. Okwera A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis AIDS 18 2004 257 264 (Pubitemid 38253448)
53. H. Mayanja-Kizza, E. Jones-Lopez, A. Okwera, R.S. Wallis, J.J. Ellner, R.D. Mugerwa, and C.C. Whalen Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda J Infect Dis 191 2005 856 865 (Pubitemid 40349799)
54. P. Manzoni, L. Decembrino, I. Stolfi, L. Pugni, M. Rinaldi, S. Cattani, M.G. Romeo, H. Messner, N. Laforgia, F. Vagnarelli, L. Memo, L. Bordignon, O.S. Saia, M. Maule, E. Gallo, M. Mostert, C. Magnani, M. Quercia, L. Bollani, R. Pedicino, L. Renzullo, P. Betta, F. Ferrari, R. Magaldi, F. Mosca, M. Stronati, and D. Farina Lactoferrin and prevention of late-onset sepsis in the pre-term neonates Early Hum Dev 86 Suppl. 1 2010 59 61
55. P. Manzoni, M. Rinaldi, S. Cattani, L. Pugni, M.G. Romeo, H. Messner, I. Stolfi, L. Decembrino, N. Laforgia, F. Vagnarelli, L. Memo, L. Bordignon, O.S. Saia, M. Maule, E. Gallo, M. Mostert, C. Magnani, M. Quercia, L. Bollani, R. Pedicino, L. Renzullo, P. Betta, F. Mosca, F. Ferrari, R. Magaldi, M. Stronati, and D. Farina Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial JAMA 302 2009 1421 1428
56. S. Tamano, K. Sekine, M. Takase, K. Yamauchi, M. Iigo, and H. Tsuda Lack of chronic oral toxicity of chemopreventive bovine lactoferrin in F344/DuCrj rats Asian Pac J Cancer Prev 9 2008 313 316
57. H. Ueno, T. Sato, S. Yamamoto, K. Tanaka, S. Ohkawa, H. Takagi, O. Yokosuka, J. Furuse, H. Saito, A. Sawaki, H. Kasugai, Y. Osaki, S. Fujiyama, K. Sato, K. Wakabayashi, and T. Okusaka Randomized, double-blind, placebo-controlled trial of bovine lactoferrin in patients with chronic hepatitis C Cancer Sci 97 2006 1105 1110 (Pubitemid 44322561)